A retrospective, cohort assessing clinical characteristics of patients with psoriasis who initiated risankizumab and other biologics in the USA
Latest Information Update: 16 Jun 2021
At a glance
- Drugs Risankizumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 16 Jun 2021 New trial record
- 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021